{
    "organizations": [],
    "uuid": "4bac3551fa4c59af78bfe2e0824e1cc53b043f69",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/lupin-results/indias-lupin-q3-profit-down-65-pct-misses-estimates-idUSL4N1PW3T6",
    "ord_in_thread": 0,
    "title": "India's Lupin Q3 profit down 65 pct, misses estimates",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 6 (Reuters) - Lupin Ltd, India’s second-largest drugmaker by revenue, on Tuesday posted a 65 percent fall in third-quarter net profit, well below analysts’ estimates.\nProfit came in at 2.22 billion rupees ($34.60 million) for the quarter ended Dec. 31, versus 6.33 billion rupees a year earlier. ( bit.ly/2E47T4m )\nThat compared with an average estimate of 4.21 billion rupees from 19 analysts polled by Thomson Reuters I/B/E/S. ($1 = 64.1550 Indian rupees) (Reporting by Jessica Kuruthukulangara in Bengaluru)\n ",
    "published": "2018-02-06T17:25:00.000+02:00",
    "crawled": "2018-02-07T21:52:04.074+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "lupin",
        "ltd",
        "india",
        "drugmaker",
        "revenue",
        "tuesday",
        "posted",
        "percent",
        "fall",
        "net",
        "profit",
        "well",
        "analyst",
        "estimate",
        "profit",
        "came",
        "billion",
        "rupee",
        "million",
        "quarter",
        "ended",
        "versus",
        "billion",
        "rupee",
        "year",
        "earlier",
        "compared",
        "average",
        "estimate",
        "billion",
        "rupee",
        "analyst",
        "polled",
        "thomson",
        "reuters",
        "indian",
        "rupee",
        "reporting",
        "jessica",
        "kuruthukulangara",
        "bengaluru"
    ]
}